Security Snapshot

AEON Biopharma, Inc. - Class A Common Stock (AEON) Institutional Ownership

CUSIP: 00791X209

13F Institutional Holders and Ownership History from Q1 2025 to Q3 2026

13F reference period

Q2 2026

Institutions Reporting

22

Shares (Excl. Options)

12.8MFull value: 12,802,787 · shares · 30 Jun 2026

Price

$0.72

The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Security type / class
Equity / Class A Common Stock
Symbol
AEON on NYSE
All holders as of 30 Jun 2026
Q2 2026
Total 13F shares
12,802,787
Latest holder snapshot 5 signals
Total 13F value
$9,215,671
Portfolio coverage rank
0%
Share change
+9,961,368
Value change
+$7,156,699
Number of holders
22
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
50,000,000
SEC-reported price per share
$0.23
Insider filing price
$0.23
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • AEON - AEON Biopharma, Inc. - Class A Common Stock is tracked under CUSIP 00791X209.
  • 22 institutions reported positions in Q2 2026.
  • 5 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 24 to 22 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from
    $2.8MFull value: $2,800,888 · USD · 31 Mar 2026
    to
    $9.22MFull value: $9,215,671 · USD · 30 Jun 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 22 institutions filings for Q2 2026.

Open SEC evidence

Security key

00791X209

13F reference period

Q2 2026

13F holders

22

13D/G owners

5

CIK / CUSIP context first

Open Q2 2026 holders AEON full holder history AEON Biopharma, Inc. SEC filings AEON Biopharma, Inc. company facts AEON Biopharma, Inc. insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
5
Security
AEON
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Stonepine Capital Management, LLC 9.9% $5,006,155 6,892,682 Stonepine Capital Management, LLC 15 Jul 2026
LYNCH TIMOTHY P 13% $1,690,000 6,500,000 Timothy P. Lynch 19 Aug 2026
Chernett Jorey 9.9% $564,250 1,128,500 Chernett Jorey 27 May 2025
Alta Partners LLC 2.1% -60% $192,400 -$259,078 249,870 -57% Alta Partners LLC 30 Sep 2025
Dauntless Investment Group, LLC 9.7% $44,372 108,224 Dauntless Investment Group, LLC 26 Feb 2025
As of 30 Jun 2026, 22 institutional investors reported holding
12.8MFull value: 12,802,787 · shares · 30 Jun 2026
shares of AEON Biopharma, Inc. - Class A Common Stock (AEON). This represents 26% of the company’s total
50MFull value: 50,000,000 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
26%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Dauntless Investment Group, LLC 25% 12,490,154 +394% 16% $8,984,168
GEODE CAPITAL MANAGEMENT, LLC 0.19% 95,311 +9.5% 0% $68,556
VANGUARD CAPITAL MANAGEMENT LLC 0.18% 90,529 0% 0% $65,090
Blue Owl Capital Holdings LP 0.08% 42,353 0% 0% $30,494
Formidable Asset Management, LLC 0.04% 20,024 0% 0% $19,724
StoneX Group Inc. 0.04% 18,953 0% $14,942
VANGUARD FIDUCIARY TRUST CO 0.03% 13,713 -6.7% 0% $9,860
LPL Financial LLC 0.02% 11,507 0% 0% $8,277
CITIGROUP INC 0.01% 7,315 +886% 0% $5,262
UBS Group AG 0.01% 5,062 +21% 0% $3,640
BlackRock, Inc. 0.01% 2,834 0% 0% $2,038
Tower Research Capital LLC (TRC) 0.01% 2,567 +446% 0% $1,846
Steward Partners Investment Advisory, LLC 0% 1,100 0% 0% $791
WOLFF WIESE MAGANA LLC 0% 567 0% 0% $408
SBI Securities Co., Ltd. 0% 232 +121% 0% $167
DUPONT CAPITAL MANAGEMENT CORP 0% 170 0% 0.01% $122
MORGAN STANLEY 0% 150 0% 0% $108
GHP Investment Advisors, Inc. 0% 95 0% 0% $69
WELLS FARGO & COMPANY/MN 0% 90 0% 0% $65
BARCLAYS PLC 0% 59 0% $42
Caitong International Asset Management Co., Ltd 0% 1 0% 0% $1
DANSKE BANK A/S 0% 1 0% 0% $1
XTX Topco Ltd 0% 0 -100% $0
MAI Capital Management 0% 0 -100% $0
JANE STREET GROUP, LLC 0% 0 -100% $0

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
7
Headline period
Q2 2026
Rows shown
1-7 of 7
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 14,017 $4,207 -$11,056 $0.30 5
2026 Q2 12,802,787 $9,215,671 +$7,156,699 $0.72 22
2026 Q1 2,841,419 $2,800,888 +$384,975 $0.99 24
2025 Q4 2,443,029 $1,667,217 +$712,814 $1.10 22
2025 Q3 1,364,447 $1,103,333 +$78,032 $0.81 21
2025 Q2 1,271,217 $585,730 -$147,232 $0.76 18
2025 Q1 1,526,776 $884,785 +$884,785 $0.58 15
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .